These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16712958)

  • 1. Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
    Breij EC; Heijnen P; van der Goes A; Teunissen CE; Polman CH; Dijkstra CD
    J Neuroimmunol; 2006 Jul; 176(1-2):106-14. PubMed ID: 16712958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis.
    Chan A; Decard BF; Franke C; Grummel V; Zhou D; Schottstedt V; Toyka KV; Hemmer B; Gold R
    Mult Scler; 2010 Oct; 16(10):1189-92. PubMed ID: 20685767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on anti-myelin antibodies in patients with multiple sclerosis.
    Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G
    Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
    Khalil M; Reindl M; Lutterotti A; Kuenz B; Ehling R; Gneiss C; Lackner P; Deisenhammer F; Berger T
    J Neuroimmunol; 2006 May; 174(1-2):147-56. PubMed ID: 16516980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
    Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A
    Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
    J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
    Xu Y; Zhang Y; Liu CY; Peng B; Wang JM; Zhang XJ; Li HF; Cui LY
    Chin Med J (Engl); 2012 Sep; 125(18):3207-10. PubMed ID: 22964310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
    Olsson T; Baig S; Höjeberg B; Link H
    Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.
    Menge T; von Büdingen HC; Lalive PH; Genain CP
    Eur J Immunol; 2007 Nov; 37(11):3229-39. PubMed ID: 17918203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of antibodies against myelin oligodendrocyte glycoprotein in different clinical types of multiple sclerosis.
    Zadro I; Brinar V; Horvat G; Brinar M
    Clin Neurol Neurosurg; 2007 Jan; 109(1):23-6. PubMed ID: 16750597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
    Lolli F; Mazzanti B; Pazzagli M; Peroni E; Alcaro MC; Sabatino G; Lanzillo R; Brescia Morra V; Santoro L; Gasperini C; Galgani S; D'Elios MM; Zipoli V; Sotgiu S; Pugliatti M; Rovero P; Chelli M; Papini AM
    J Neuroimmunol; 2005 Oct; 167(1-2):131-7. PubMed ID: 16051375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
    Pröbstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gärtner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
    Neurology; 2011 Aug; 77(6):580-8. PubMed ID: 21795651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis.
    Haghighi S; Lekman A; Nilsson S; Blomqvist M; Andersen O
    Acta Neurol Scand; 2012 Jan; 125(1):64-70. PubMed ID: 21707550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
    Roussel V; Yi F; Jauberteau MO; Couderq C; Lacombe C; Michelet V; Gil R; Couratier P; Vallat JM; Preud'homme JL
    J Autoimmun; 2000 May; 14(3):259-65. PubMed ID: 10756088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.